S. comparative review with etidronate disodium 400 mg/day. The subsequent figure displays the necessarily mean percent adjustments from baseline in serum alkaline phosphatase for approximately six months of randomized therapy.A bisphosphonate which inhibits bone resorption through actions on osteoclasts or on osteoclast precursors; decreases the s